FDA approves etravirine for treatment-experienced children 6 to 18 years of age and new scored 25 mg tablet for paediatric dosing
1 April 2012. Related: Antiretrovirals, Paediatric care.
2012
Why global health activists are fired up about Novartis
1 April 2012. Related: Treatment access.
Obama’s global, domestic & HIV research budget backslides on existing commitments
1 April 2012. Related: Treatment access.
FDA reject capsaicin patch for HIV-related neuropathy
1 April 2012. Related: Side effects.
US HHS adult treatment guidelines updated (March 2012)
1 April 2012. Related: Guidelines.
FDA warning of drug interactions between boceprevir and some HIV protease inhibitors
1 April 2012. Related: PK and drug interactions.
Free comic book for HIV positive children about CD4, viral load and ARV treatment
1 April 2012. Related: Other news.
Free full text online articles
1 April 2012. Related: On the web.
Volume 13 Number 3/4 March/April 2012 PDF
1 April 2012. Related: PDFs.
2nd International Workshop on HIV & Women, 9-10 January 2012, Bethesda, USA
1 February 2012. Related: Conference reports.
Similar efficacy and a few gender related differences in side effects with rilpivirine vs efavirenz at 96-weeks
1 February 2012. Related: Conference reports, Antiretrovirals, Pregnancy.
Volume 13 Number 1/2 January/February 2012
1 February 2012. Related: Editorial.
The effect of BMI on efficacy, safety and tolerability of lopinavir/r in women
1 February 2012. Related: Conference reports, Antiretrovirals, Women's health.
Hormonal contraception and higher risk of non-AIDS-defining events in Nashville cohort
1 February 2012. Related: Conference reports, Women's health.
Poorer adherence and loss to follow up in Kenyan women who are pregnant when enrolled to ART programmes
1 February 2012. Related: Conference reports, Antiretrovirals, Pregnancy.
5th HIV Persistence Workshop on HIV Reservoirs, 6-9 December 2011, West Indies
1 February 2012. Related: Conference reports, Cure-related research, Basic science and immunology, Virology.
Workshop report and commentary: HIV persistence and reservoirs
1 February 2012. Related: Conference reports, Cure-related research, Basic science and immunology, Virology.
Nevirapine prolonged release (PR) once-daily formulation available in the UK
1 February 2012. Related: Antiretrovirals.
Etravirine 200 mg formulation available in UK
1 February 2012. Related: Antiretrovirals.
Tenofovir label extended to paediatric indication
1 February 2012. Related: Antiretrovirals.
FDA approve US paediatric dose for raltegravir
1 February 2012. Related: Antiretrovirals.
FDA approve paediatric dose for darunavir
1 February 2012. Related: Antiretrovirals.
Efavirenz dose increase to 800 mg QD with rifampin in patients >50 kg
1 February 2012. Related: Antiretrovirals.
FDA approval of generic ARVs
1 February 2012. Related: Treatment access.
Disastrous warning for global HIV programmes in 2012
1 February 2012. Related: Treatment access.
Janssen block Patent Pool access to darunavir, rilpivirine and etravrine
1 February 2012. Related: Treatment access.
UNITAID continues funding the Patent Pool, paediatric HIV medicines and malaria
1 February 2012. Related: Treatment access.
Michel Kazatchkine resigns from Global Fund: Gabriel Jaramillo, Brazilian banker, to serve as general manager
1 February 2012. Related: Treatment access.
Call to Action on Global Fund restriction to new funding to 2014
1 February 2012. Related: Treatment access.
Analysis of why the Global Fund cancelled Round 11
1 February 2012. Related: Treatment access.
Reaction to the Global Fund's decisions on Round 11 and grant renewals
1 February 2012. Related: Treatment access.
Activists oppose Gates Foundation funding study using low dose d4T
1 February 2012. Related: Treatment access.
Delaying ART in childhood can reduce long-term CD4 count in adulthood
1 February 2012. Related: Paediatric care.
No increased risk of non-AIDS deaths from cumulative use of ART in EuroSIDA cohort
1 February 2012. Related: Coinfections and complications.
Need for expanded access to two promising MDR TB drugs
1 February 2012. Related: TB coinfection.
Interactions between nevirapine and antimalarials (artemether and lumefantrine)
1 February 2012. Related: PK and drug interactions.
Interactions between antiretrovirals and complementary and African traditional medicines
1 February 2012. Related: PK and drug interactions.
Drug interactions between sirolimus (rapamycin) and ARVs
1 February 2012. Related: PK and drug interactions.
Supplement: HIV testing and risks of sexual transmission
1 February 2012. Related: Special reports.
Draft BHIVA ARV treatment guidelines online for comment until 5 March
1 February 2012. Related: Guidelines.
Contraceptive failure with etonogestrel implants and efavirenz: case reports
1 February 2012. Related: PK and drug interactions.
BHIVA guidelines for the routine investigation and monitoring of adult HIV (2011)
1 February 2012. Related: Guidelines.
Draft BHIVA pregnancy guidelines online for comment until 5 March
1 February 2012. Related: Guidelines.
NICE guidance on increasing the uptake of HIV testing
1 February 2012. Related: HIV prevention and transmission.
London Commissioning: new announcements
1 February 2012. Related: Other news.
Testosterone: A man's guide: practical tips for boosting physical, mental and sexual vitality; by Nelson Vergel
1 February 2012. Related: Book and film reviews.
2011 HIV Persistence Workshop
1 February 2012. Related: On the web.
A Call for Comprehensive Responses to HIV in People Who Use Drugs
1 February 2012. Related: On the web.
Achieving a cure for HIV infection: do we have reasons to be optimistic?
1 February 2012. Related: Cure-related research, On the web.
Volume 13 Number 1/2 January/February 2012 PDF
1 February 2012. Related: PDFs.